After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV -- and more are on the way. On Wednesday, the US Food and Drug Administration ...

Uptake of the respiratory syncytial virus (RSV) vaccine during pregnancy is not linked to increased risk of adverse perinatal health outcomes among vaccinated women, according to research at City St ...

Merck (NYSE:MRK) announced on Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed Enflonsia, a prophylactic antibody therapy developed by the company to ...

Merck Receives Positive EU CHMP Opinion for ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) in Infants During Their First RSV Season If approved by the European ...